Found 15 matching trials
A Study of RO4917838 (Bitopertin) in Patients With Persistent, Predominant Negative Symptoms of Schizophrenia (WN25309) PHASE3 This multi-center, randomized, double blind, parallel-group, placebo-contro...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Bitopertin (RO4917838) in Healthy Male Volunteers PHASE1 This randomized, double-blind, placebo-controlled, dose-escalating study wi...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of RO4917838 (Bitopertin) in Patients With Acute Exacerbation of Schizophrenia PHASE2 This randomized, double-blind, placebo- and active-controlled, parallel gro...
Show More Location
Multiple Locations
Learn More & Join Trial
Expanded Access Program of Bitopertin For Participants With EPP or XLP N/A The goal of this expanded access program is to provide bitopertin to patien...
Show More Location
University of Miami Miller School of Medicine
Learn More & Join Trial
Study of the Selective GlyT1 Inhibitor Bitopertin for Steroid-Refractory Diamond-Blackfan Anemia PHASE1 Background:
Diamond-Blackfan anemia (DBA) is an inherited disease that aff...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
A Study to Evaluate Efficacy and Safety of Bitopertin in Participants With Persistent, Predominant Negative Symptoms of Schizophrenia PHASE3 This Phase 3, multi-center, randomized, double blind, parallel-group, place...
Show More Location
Clinical Innovtions Inc
Learn More & Join Trial
Study of Bitopertin to Evaluate the Safety, Tolerability, Efficacy, and PPIX Concentrations in Participants With EPP PHASE2 This is a Phase 2, multi-center, double-blind, placebo-controlled, parallel...
Show More Location
University of Alabama Hospital
Learn More & Join Trial
A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors (SSRIs) in Participants With Obsessive-Compulsive Disorder (OCD) PHASE2 This multicenter, randomized, double-blind, parallel-group, placebo-control...
Show More Learn More & Join Trial
A Study of RO4917838 (Bitopertin) in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (WN25306) PHASE3 This randomized, multi-center, double-blind, parallel-group, placebo-contro...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study Exmining the Effect of Multiple Doses of Bitopertin on the Single Dose Pharmacokinetics of Midazolam in Healthy Volunteers. PHASE1 This will be a single-center, open-label, inpatient/outpatient, fixed-seque...
Show More Location
Multiple Locations
Learn More & Join Trial